14.85

5.39% 0.76

After Hours: 14.85

Core Laboratories Inc (CLB)

Overview News Price History Option Chain Discussions Forecast Stock Split Dividend History

Core Laboratories Inc stock is traded at $14.85, with a volume of 399.21K. It is up +5.39% in the last 24 hours and down -10.43% over the past month. Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.

Previous Close:

$14.09

Open:

$14.16

24h Volume:

399.21K

Relative Volume:

1.31

Market Cap:

$695.38M

Revenue:

$502.79M

Net Income/Loss:

$23.71M

P/E Ratio:

29.70

EPS:

0.5

Net Cash Flow:

$6.35M

1W Performance:

+1.50%

1M Performance:

-10.43%

6M Performance:

-16.05%

1Y Performance:

-7.01%

1-Day Range:

$14.12

$15.00

1-Week Range:

$12.95

$15.00

52-Week Range:

$12.95

$25.13

Core Laboratories Inc Stock (CLB) Company Profile

Name

Core Laboratories Inc

Sector

Energy (252)

Industry

Oil & Gas Equipment & Services (70)

Phone

713-328-2673

Address

6316 WINDFERN ROAD, HOUSTON

Employee

3,500

Twitter

@corelabcompany

Next Earnings Date

2025-01-29

Latest SEC Filings

CLB's Discussions on Twitter

Compare CLB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CLB Core Laboratories Inc	14.85	695.38M	502.79M	23.71M	6.35M	0.50
SLB Schlumberger Ltd	41.37	58.74B	36.29B	4.46B	4.47B	3.11
BKR Baker Hughes Company	42.89	42.47B	27.83B	2.98B	2.05B	2.98
HAL Halliburton Co	25.00	21.70B	22.94B	2.50B	2.42B	2.83
TS Tenaris S A Adr	37.23	21.34B	13.09B	2.65B	2.52B	4.5936
FTI Technipfmc Plc	26.67	11.22B	8.79B	671.20M	856.30M	1.52

Core Laboratories Inc Stock (CLB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-30-23	Downgrade	Citigroup	Neutral → Sell
Apr-18-23	Downgrade	BofA Securities	Neutral → Underperform
Jan-09-23	Upgrade	BofA Securities	Underperform → Neutral
Oct-07-22	Upgrade	Citigroup	Sell → Neutral
Sep-26-22	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Apr-18-22	Downgrade	Piper Sandler	Neutral → Underweight
Oct-18-21	Downgrade	BofA Securities	Neutral → Underperform
Jul-09-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-14-21	Downgrade	Citigroup	Neutral → Sell
Dec-18-20	Downgrade	JP Morgan	Neutral → Underweight
Nov-11-20	Reiterated	Cowen	Market Perform
Oct-13-20	Upgrade	BofA Securities	Underperform → Neutral
Sep-29-20	Upgrade	ABN Amro	Sell → Hold
Jul-16-20	Downgrade	Scotiabank	Sector Outperform → Sector Perform
Apr-13-20	Upgrade	Scotiabank	Sector Perform → Sector Outperform
Mar-09-20	Downgrade	BofA/Merrill	Buy → Underperform
Mar-09-20	Downgrade	Evercore ISI	Outperform → In-line
Jan-31-20	Reiterated	Cowen	Market Perform
Jan-30-20	Resumed	Johnson Rice	Buy
Jan-14-20	Initiated	Bernstein	Mkt Perform
Jan-02-20	Downgrade	Stifel	Buy → Hold
Dec-31-19	Reiterated	Cowen	Market Perform
Jul-10-19	Upgrade	BofA/Merrill	Neutral → Buy
Feb-25-19	Upgrade	Tudor Pickering	Hold → Buy
Dec-19-18	Downgrade	Credit Suisse	Outperform → Neutral
Dec-11-18	Downgrade	JP Morgan	Overweight → Neutral
Nov-16-18	Upgrade	Guggenheim	Neutral → Buy
Nov-01-18	Upgrade	ABN Amro	Sell → Buy
Oct-29-18	Reiterated	Cowen	Market Perform

View All

Core Laboratories Inc Stock (CLB) Latest News

Mar 09, 2025

Core Laboratories (NYSE:CLB) Hits New 52-Week LowHere's What Happened - MarketBeat

Mar 09, 2025

Mar 08, 2025

Fisher Asset Management LLC Has $16.29 Million Stock Position in Core Laboratories Inc. (NYSE:CLB) - MarketBeat

Mar 08, 2025

Mar 06, 2025

Core Laboratories (NYSE:CLB) Shares Down 4.9%Here's Why - MarketBeat

Mar 06, 2025

Zephirin Adjusts Price Target on Core Laboratories to $18 From $22, Maintains Buy Rating - Marketscreener.com

Mar 06, 2025

The three-year underlying earnings growth at Core Laboratories (NYSE:CLB) is promising, but the shareholders are still in the red over that time - Simply Wall St

Mar 06, 2025

Mar 05, 2025

Principal Financial Group Inc. Grows Position in Core Laboratories Inc. (NYSE:CLB) - Defense World

Mar 05, 2025

Mar 04, 2025

Rhumbline Advisers Decreases Stake in Core Laboratories Inc. (NYSE:CLB) - Defense World

Mar 04, 2025

Mar 03, 2025

Is Core Stock Worth Buying After a 27% Surge in 6 Months? - Yahoo Finance

Mar 03, 2025

Feb 28, 2025

Why Is Core Laboratories (CLB) Down 16% Since Last Earnings Report? - Yahoo Finance

Feb 28, 2025

Feb 27, 2025

Dividend Coverage: This Energy Services Company has a Dividend Yield of 2.32%; Will Trade Ex-Dividend on October 19, 2017 - ACCESS Newswire

Feb 27, 2025

Core Laboratories stock hits 52-week low at $14.61 - Investing.com

Feb 27, 2025

Feb 24, 2025

Citigroup Forecasts Strong Price Appreciation for Core Laboratories (NYSE:CLB) Stock - MarketBeat

Feb 24, 2025

Feb 23, 2025

Kornitzer Capital Management Inc. KS Purchases Shares of 35,515 Core Laboratories Inc. (NYSE:CLB) - MarketBeat

Feb 23, 2025

Feb 21, 2025

Van ECK Associates Corp Acquires 26,237 Shares of Core Laboratories Inc. (NYSE:CLB) - MarketBeat

Feb 21, 2025

Feb 20, 2025

The past five years for Core Laboratories (NYSE:CLB) investors has not been profitable - Yahoo Finance

Feb 20, 2025

Feb 19, 2025

Rice Hall James & Associates LLC Buys New Shares in Core Laboratories Inc. (NYSE:CLB) - MarketBeat

Feb 19, 2025

Feb 18, 2025

Van ECK Associates Corp Boosts Stock Holdings in Core Laboratories Inc. (NYSE:CLB) - Defense World

Feb 18, 2025

Feb 13, 2025

Core Laboratories Inc. /DE/ SEC 10-K Report - TradingView

Feb 13, 2025

Feb 08, 2025

Core Laboratories Inc. (NYSE:CLB) Stock Holdings Lifted by Boston Trust Walden Corp - MarketBeat

Feb 08, 2025

Feb 07, 2025